nodes	percent_of_prediction	percent_of_DWPC	metapath
Posaconazole—ABCB1—Mitoxantrone—lymphatic system cancer	0.108	0.207	CbGbCtD
Posaconazole—CYP3A4—Cytarabine—lymphatic system cancer	0.0937	0.18	CbGbCtD
Posaconazole—CYP3A4—Teniposide—lymphatic system cancer	0.0923	0.177	CbGbCtD
Posaconazole—ABCB1—Vincristine—lymphatic system cancer	0.0741	0.142	CbGbCtD
Posaconazole—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0645	0.124	CbGbCtD
Posaconazole—ABCB1—Methotrexate—lymphatic system cancer	0.0449	0.086	CbGbCtD
Posaconazole—CYP3A4—Vincristine—lymphatic system cancer	0.0444	0.0852	CbGbCtD
Posaconazole—Confusional state—Bleomycin—lymphatic system cancer	0.000389	0.000813	CcSEcCtD
Posaconazole—Vision blurred—Carmustine—lymphatic system cancer	0.000389	0.000812	CcSEcCtD
Posaconazole—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000387	0.00081	CcSEcCtD
Posaconazole—Tremor—Carmustine—lymphatic system cancer	0.000386	0.000808	CcSEcCtD
Posaconazole—Oedema—Bleomycin—lymphatic system cancer	0.000386	0.000806	CcSEcCtD
Posaconazole—Erythema—Mitoxantrone—lymphatic system cancer	0.000383	0.000801	CcSEcCtD
Posaconazole—Infection—Bleomycin—lymphatic system cancer	0.000383	0.000801	CcSEcCtD
Posaconazole—Anaemia—Carmustine—lymphatic system cancer	0.000381	0.000797	CcSEcCtD
Posaconazole—Back pain—Vincristine—lymphatic system cancer	0.000381	0.000796	CcSEcCtD
Posaconazole—Vomiting—Teniposide—lymphatic system cancer	0.00038	0.000795	CcSEcCtD
Posaconazole—Sepsis—Methotrexate—lymphatic system cancer	0.000379	0.000793	CcSEcCtD
Posaconazole—Agitation—Carmustine—lymphatic system cancer	0.000379	0.000792	CcSEcCtD
Posaconazole—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000378	0.000789	CcSEcCtD
Posaconazole—Asthenia—Fludarabine—lymphatic system cancer	0.000377	0.000789	CcSEcCtD
Posaconazole—Rash—Teniposide—lymphatic system cancer	0.000377	0.000789	CcSEcCtD
Posaconazole—Dermatitis—Teniposide—lymphatic system cancer	0.000377	0.000788	CcSEcCtD
Posaconazole—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000375	0.000785	CcSEcCtD
Posaconazole—Headache—Teniposide—lymphatic system cancer	0.000375	0.000784	CcSEcCtD
Posaconazole—Pruritus—Fludarabine—lymphatic system cancer	0.000372	0.000778	CcSEcCtD
Posaconazole—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.000372	0.000777	CcSEcCtD
Posaconazole—Back pain—Mitoxantrone—lymphatic system cancer	0.000371	0.000775	CcSEcCtD
Posaconazole—Leukopenia—Carmustine—lymphatic system cancer	0.000369	0.000772	CcSEcCtD
Posaconazole—Anorexia—Bleomycin—lymphatic system cancer	0.000368	0.000768	CcSEcCtD
Posaconazole—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.000366	0.000766	CcSEcCtD
Posaconazole—Anaemia—Vincristine—lymphatic system cancer	0.000364	0.000761	CcSEcCtD
Posaconazole—Agitation—Vincristine—lymphatic system cancer	0.000362	0.000756	CcSEcCtD
Posaconazole—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000361	0.000755	CcSEcCtD
Posaconazole—Hypotension—Bleomycin—lymphatic system cancer	0.00036	0.000753	CcSEcCtD
Posaconazole—Diarrhoea—Fludarabine—lymphatic system cancer	0.00036	0.000752	CcSEcCtD
Posaconazole—Convulsion—Carmustine—lymphatic system cancer	0.000357	0.000747	CcSEcCtD
Posaconazole—Hypertension—Carmustine—lymphatic system cancer	0.000356	0.000744	CcSEcCtD
Posaconazole—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000356	0.000744	CcSEcCtD
Posaconazole—Nausea—Teniposide—lymphatic system cancer	0.000355	0.000743	CcSEcCtD
Posaconazole—Anaemia—Mitoxantrone—lymphatic system cancer	0.000354	0.000741	CcSEcCtD
Posaconazole—Vertigo—Vincristine—lymphatic system cancer	0.000354	0.000739	CcSEcCtD
Posaconazole—Hepatic failure—Methotrexate—lymphatic system cancer	0.000353	0.000738	CcSEcCtD
Posaconazole—Leukopenia—Vincristine—lymphatic system cancer	0.000352	0.000737	CcSEcCtD
Posaconazole—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000351	0.000734	CcSEcCtD
Posaconazole—Myalgia—Carmustine—lymphatic system cancer	0.000351	0.000734	CcSEcCtD
Posaconazole—Chest pain—Carmustine—lymphatic system cancer	0.000351	0.000734	CcSEcCtD
Posaconazole—Anxiety—Carmustine—lymphatic system cancer	0.00035	0.000731	CcSEcCtD
Posaconazole—Paraesthesia—Bleomycin—lymphatic system cancer	0.000346	0.000724	CcSEcCtD
Posaconazole—Malaise—Mitoxantrone—lymphatic system cancer	0.000346	0.000723	CcSEcCtD
Posaconazole—Dyspnoea—Bleomycin—lymphatic system cancer	0.000344	0.000719	CcSEcCtD
Posaconazole—Renal failure acute—Methotrexate—lymphatic system cancer	0.000344	0.000718	CcSEcCtD
Posaconazole—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000343	0.000717	CcSEcCtD
Posaconazole—Convulsion—Vincristine—lymphatic system cancer	0.000341	0.000713	CcSEcCtD
Posaconazole—Hypertension—Vincristine—lymphatic system cancer	0.00034	0.00071	CcSEcCtD
Posaconazole—Confusional state—Carmustine—lymphatic system cancer	0.000339	0.000709	CcSEcCtD
Posaconazole—Oedema—Carmustine—lymphatic system cancer	0.000337	0.000704	CcSEcCtD
Posaconazole—Decreased appetite—Bleomycin—lymphatic system cancer	0.000335	0.000701	CcSEcCtD
Posaconazole—Myalgia—Vincristine—lymphatic system cancer	0.000335	0.000701	CcSEcCtD
Posaconazole—Cough—Mitoxantrone—lymphatic system cancer	0.000335	0.000699	CcSEcCtD
Posaconazole—Infection—Carmustine—lymphatic system cancer	0.000334	0.000699	CcSEcCtD
Posaconazole—Vomiting—Fludarabine—lymphatic system cancer	0.000334	0.000699	CcSEcCtD
Posaconazole—Convulsion—Mitoxantrone—lymphatic system cancer	0.000332	0.000694	CcSEcCtD
Posaconazole—Rash—Fludarabine—lymphatic system cancer	0.000332	0.000693	CcSEcCtD
Posaconazole—Dermatitis—Fludarabine—lymphatic system cancer	0.000331	0.000692	CcSEcCtD
Posaconazole—Hypertension—Mitoxantrone—lymphatic system cancer	0.000331	0.000692	CcSEcCtD
Posaconazole—Pain—Bleomycin—lymphatic system cancer	0.00033	0.000689	CcSEcCtD
Posaconazole—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00033	0.000689	CcSEcCtD
Posaconazole—Headache—Fludarabine—lymphatic system cancer	0.000329	0.000689	CcSEcCtD
Posaconazole—Tachycardia—Carmustine—lymphatic system cancer	0.000328	0.000687	CcSEcCtD
Posaconazole—Chest pain—Mitoxantrone—lymphatic system cancer	0.000326	0.000682	CcSEcCtD
Posaconazole—Myalgia—Mitoxantrone—lymphatic system cancer	0.000326	0.000682	CcSEcCtD
Posaconazole—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000326	0.000682	CcSEcCtD
Posaconazole—Anxiety—Mitoxantrone—lymphatic system cancer	0.000325	0.00068	CcSEcCtD
Posaconazole—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.000324	0.000677	CcSEcCtD
Posaconazole—Discomfort—Mitoxantrone—lymphatic system cancer	0.000322	0.000674	CcSEcCtD
Posaconazole—Oedema—Vincristine—lymphatic system cancer	0.000321	0.000672	CcSEcCtD
Posaconazole—Anorexia—Carmustine—lymphatic system cancer	0.000321	0.000671	CcSEcCtD
Posaconazole—Infection—Vincristine—lymphatic system cancer	0.000319	0.000667	CcSEcCtD
Posaconazole—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000318	0.000664	CcSEcCtD
Posaconazole—Confusional state—Mitoxantrone—lymphatic system cancer	0.000315	0.000659	CcSEcCtD
Posaconazole—Nervous system disorder—Vincristine—lymphatic system cancer	0.000315	0.000659	CcSEcCtD
Posaconazole—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000315	0.000658	CcSEcCtD
Posaconazole—Hypotension—Carmustine—lymphatic system cancer	0.000314	0.000657	CcSEcCtD
Posaconazole—Oedema—Mitoxantrone—lymphatic system cancer	0.000313	0.000654	CcSEcCtD
Posaconazole—Nausea—Fludarabine—lymphatic system cancer	0.000312	0.000653	CcSEcCtD
Posaconazole—Infection—Mitoxantrone—lymphatic system cancer	0.000311	0.00065	CcSEcCtD
Posaconazole—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000311	0.000649	CcSEcCtD
Posaconazole—Shock—Mitoxantrone—lymphatic system cancer	0.000308	0.000643	CcSEcCtD
Posaconazole—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000307	0.000641	CcSEcCtD
Posaconazole—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000306	0.00064	CcSEcCtD
Posaconazole—Urticaria—Bleomycin—lymphatic system cancer	0.000306	0.00064	CcSEcCtD
Posaconazole—Anorexia—Vincristine—lymphatic system cancer	0.000306	0.00064	CcSEcCtD
Posaconazole—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000305	0.000638	CcSEcCtD
Posaconazole—Body temperature increased—Bleomycin—lymphatic system cancer	0.000305	0.000637	CcSEcCtD
Posaconazole—Insomnia—Carmustine—lymphatic system cancer	0.000304	0.000636	CcSEcCtD
Posaconazole—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000304	0.000635	CcSEcCtD
Posaconazole—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000302	0.000632	CcSEcCtD
Posaconazole—Paraesthesia—Carmustine—lymphatic system cancer	0.000302	0.000632	CcSEcCtD
Posaconazole—Mood swings—Methotrexate—lymphatic system cancer	0.0003	0.000628	CcSEcCtD
Posaconazole—Hypotension—Vincristine—lymphatic system cancer	0.0003	0.000628	CcSEcCtD
Posaconazole—Dyspnoea—Carmustine—lymphatic system cancer	0.0003	0.000627	CcSEcCtD
Posaconazole—Somnolence—Carmustine—lymphatic system cancer	0.000299	0.000625	CcSEcCtD
Posaconazole—Anorexia—Mitoxantrone—lymphatic system cancer	0.000298	0.000623	CcSEcCtD
Posaconazole—Ataxia—Methotrexate—lymphatic system cancer	0.000298	0.000623	CcSEcCtD
Posaconazole—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000293	0.000612	CcSEcCtD
Posaconazole—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000293	0.000612	CcSEcCtD
Posaconazole—Decreased appetite—Carmustine—lymphatic system cancer	0.000293	0.000612	CcSEcCtD
Posaconazole—Hypotension—Mitoxantrone—lymphatic system cancer	0.000292	0.000611	CcSEcCtD
Posaconazole—Insomnia—Vincristine—lymphatic system cancer	0.000291	0.000607	CcSEcCtD
Posaconazole—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000291	0.000607	CcSEcCtD
Posaconazole—Paraesthesia—Vincristine—lymphatic system cancer	0.000288	0.000603	CcSEcCtD
Posaconazole—Pain—Carmustine—lymphatic system cancer	0.000288	0.000602	CcSEcCtD
Posaconazole—Constipation—Carmustine—lymphatic system cancer	0.000288	0.000602	CcSEcCtD
Posaconazole—Breast disorder—Methotrexate—lymphatic system cancer	0.000287	0.000599	CcSEcCtD
Posaconazole—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000285	0.000596	CcSEcCtD
Posaconazole—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000284	0.000594	CcSEcCtD
Posaconazole—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000281	0.000587	CcSEcCtD
Posaconazole—Decreased appetite—Vincristine—lymphatic system cancer	0.000279	0.000584	CcSEcCtD
Posaconazole—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000279	0.000583	CcSEcCtD
Posaconazole—Somnolence—Mitoxantrone—lymphatic system cancer	0.000278	0.000581	CcSEcCtD
Posaconazole—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000277	0.00058	CcSEcCtD
Posaconazole—Feeling abnormal—Carmustine—lymphatic system cancer	0.000277	0.00058	CcSEcCtD
Posaconazole—Fatigue—Vincristine—lymphatic system cancer	0.000277	0.000579	CcSEcCtD
Posaconazole—Asthenia—Bleomycin—lymphatic system cancer	0.000277	0.000578	CcSEcCtD
Posaconazole—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000275	0.000576	CcSEcCtD
Posaconazole—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000275	0.000575	CcSEcCtD
Posaconazole—Pain—Vincristine—lymphatic system cancer	0.000275	0.000574	CcSEcCtD
Posaconazole—Constipation—Vincristine—lymphatic system cancer	0.000275	0.000574	CcSEcCtD
Posaconazole—Pruritus—Bleomycin—lymphatic system cancer	0.000273	0.00057	CcSEcCtD
Posaconazole—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000272	0.000569	CcSEcCtD
Posaconazole—Eosinophilia—Methotrexate—lymphatic system cancer	0.000271	0.000567	CcSEcCtD
Posaconazole—Fatigue—Mitoxantrone—lymphatic system cancer	0.00027	0.000564	CcSEcCtD
Posaconazole—Pancreatitis—Methotrexate—lymphatic system cancer	0.000269	0.000562	CcSEcCtD
Posaconazole—Constipation—Mitoxantrone—lymphatic system cancer	0.000268	0.000559	CcSEcCtD
Posaconazole—Pain—Mitoxantrone—lymphatic system cancer	0.000268	0.000559	CcSEcCtD
Posaconazole—Abdominal pain—Carmustine—lymphatic system cancer	0.000266	0.000556	CcSEcCtD
Posaconazole—Body temperature increased—Carmustine—lymphatic system cancer	0.000266	0.000556	CcSEcCtD
Posaconazole—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000263	0.000549	CcSEcCtD
Posaconazole—Pancytopenia—Methotrexate—lymphatic system cancer	0.00026	0.000544	CcSEcCtD
Posaconazole—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000258	0.000539	CcSEcCtD
Posaconazole—Neutropenia—Methotrexate—lymphatic system cancer	0.000256	0.000536	CcSEcCtD
Posaconazole—Dysuria—Methotrexate—lymphatic system cancer	0.000256	0.000536	CcSEcCtD
Posaconazole—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000256	0.000535	CcSEcCtD
Posaconazole—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.000255	0.000533	CcSEcCtD
Posaconazole—Abdominal pain—Vincristine—lymphatic system cancer	0.000254	0.000531	CcSEcCtD
Posaconazole—Body temperature increased—Vincristine—lymphatic system cancer	0.000254	0.000531	CcSEcCtD
Posaconazole—Urticaria—Mitoxantrone—lymphatic system cancer	0.000249	0.00052	CcSEcCtD
Posaconazole—Hypersensitivity—Carmustine—lymphatic system cancer	0.000248	0.000518	CcSEcCtD
Posaconazole—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000247	0.000517	CcSEcCtD
Posaconazole—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000247	0.000517	CcSEcCtD
Posaconazole—Pneumonia—Methotrexate—lymphatic system cancer	0.000246	0.000514	CcSEcCtD
Posaconazole—Vomiting—Bleomycin—lymphatic system cancer	0.000245	0.000512	CcSEcCtD
Posaconazole—Infestation NOS—Methotrexate—lymphatic system cancer	0.000244	0.000511	CcSEcCtD
Posaconazole—Infestation—Methotrexate—lymphatic system cancer	0.000244	0.000511	CcSEcCtD
Posaconazole—Rash—Bleomycin—lymphatic system cancer	0.000243	0.000508	CcSEcCtD
Posaconazole—Dermatitis—Bleomycin—lymphatic system cancer	0.000243	0.000508	CcSEcCtD
Posaconazole—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000242	0.000507	CcSEcCtD
Posaconazole—Asthenia—Carmustine—lymphatic system cancer	0.000241	0.000505	CcSEcCtD
Posaconazole—Renal failure—Methotrexate—lymphatic system cancer	0.00024	0.000502	CcSEcCtD
Posaconazole—Stomatitis—Methotrexate—lymphatic system cancer	0.000238	0.000498	CcSEcCtD
Posaconazole—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000238	0.000497	CcSEcCtD
Posaconazole—Hypersensitivity—Vincristine—lymphatic system cancer	0.000237	0.000495	CcSEcCtD
Posaconazole—Haematuria—Methotrexate—lymphatic system cancer	0.000233	0.000487	CcSEcCtD
Posaconazole—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000231	0.000483	CcSEcCtD
Posaconazole—Epistaxis—Methotrexate—lymphatic system cancer	0.000231	0.000482	CcSEcCtD
Posaconazole—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000231	0.000482	CcSEcCtD
Posaconazole—Asthenia—Vincristine—lymphatic system cancer	0.000231	0.000482	CcSEcCtD
Posaconazole—Diarrhoea—Carmustine—lymphatic system cancer	0.00023	0.000481	CcSEcCtD
Posaconazole—Nausea—Bleomycin—lymphatic system cancer	0.000229	0.000479	CcSEcCtD
Posaconazole—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000228	0.000477	CcSEcCtD
Posaconazole—Asthenia—Mitoxantrone—lymphatic system cancer	0.000224	0.000469	CcSEcCtD
Posaconazole—Dizziness—Carmustine—lymphatic system cancer	0.000223	0.000465	CcSEcCtD
Posaconazole—Haemoglobin—Methotrexate—lymphatic system cancer	0.000221	0.000461	CcSEcCtD
Posaconazole—Diarrhoea—Vincristine—lymphatic system cancer	0.00022	0.00046	CcSEcCtD
Posaconazole—Haemorrhage—Methotrexate—lymphatic system cancer	0.000219	0.000459	CcSEcCtD
Posaconazole—Hepatitis—Methotrexate—lymphatic system cancer	0.000219	0.000459	CcSEcCtD
Posaconazole—Pharyngitis—Methotrexate—lymphatic system cancer	0.000218	0.000455	CcSEcCtD
Posaconazole—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000217	0.000453	CcSEcCtD
Posaconazole—Urethral disorder—Methotrexate—lymphatic system cancer	0.000215	0.00045	CcSEcCtD
Posaconazole—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000214	0.000448	CcSEcCtD
Posaconazole—Vomiting—Carmustine—lymphatic system cancer	0.000214	0.000447	CcSEcCtD
Posaconazole—Dizziness—Vincristine—lymphatic system cancer	0.000212	0.000444	CcSEcCtD
Posaconazole—Rash—Carmustine—lymphatic system cancer	0.000212	0.000444	CcSEcCtD
Posaconazole—Dermatitis—Carmustine—lymphatic system cancer	0.000212	0.000443	CcSEcCtD
Posaconazole—Headache—Carmustine—lymphatic system cancer	0.000211	0.000441	CcSEcCtD
Posaconazole—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000207	0.000434	CcSEcCtD
Posaconazole—Eye disorder—Methotrexate—lymphatic system cancer	0.000205	0.000429	CcSEcCtD
Posaconazole—Tinnitus—Methotrexate—lymphatic system cancer	0.000205	0.000428	CcSEcCtD
Posaconazole—Vomiting—Vincristine—lymphatic system cancer	0.000204	0.000427	CcSEcCtD
Posaconazole—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000204	0.000426	CcSEcCtD
Posaconazole—Rash—Vincristine—lymphatic system cancer	0.000203	0.000423	CcSEcCtD
Posaconazole—Dermatitis—Vincristine—lymphatic system cancer	0.000202	0.000423	CcSEcCtD
Posaconazole—Headache—Vincristine—lymphatic system cancer	0.000201	0.000421	CcSEcCtD
Posaconazole—Nausea—Carmustine—lymphatic system cancer	0.0002	0.000418	CcSEcCtD
Posaconazole—Angiopathy—Methotrexate—lymphatic system cancer	0.000199	0.000416	CcSEcCtD
Posaconazole—Vomiting—Mitoxantrone—lymphatic system cancer	0.000199	0.000416	CcSEcCtD
Posaconazole—Immune system disorder—Methotrexate—lymphatic system cancer	0.000198	0.000414	CcSEcCtD
Posaconazole—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000198	0.000413	CcSEcCtD
Posaconazole—Rash—Mitoxantrone—lymphatic system cancer	0.000197	0.000412	CcSEcCtD
Posaconazole—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000197	0.000412	CcSEcCtD
Posaconazole—Chills—Methotrexate—lymphatic system cancer	0.000197	0.000412	CcSEcCtD
Posaconazole—Headache—Mitoxantrone—lymphatic system cancer	0.000196	0.00041	CcSEcCtD
Posaconazole—Alopecia—Methotrexate—lymphatic system cancer	0.000194	0.000405	CcSEcCtD
Posaconazole—Mental disorder—Methotrexate—lymphatic system cancer	0.000192	0.000402	CcSEcCtD
Posaconazole—Erythema—Methotrexate—lymphatic system cancer	0.000191	0.000399	CcSEcCtD
Posaconazole—Malnutrition—Methotrexate—lymphatic system cancer	0.000191	0.000399	CcSEcCtD
Posaconazole—Nausea—Vincristine—lymphatic system cancer	0.000191	0.000399	CcSEcCtD
Posaconazole—Dysgeusia—Methotrexate—lymphatic system cancer	0.000187	0.000391	CcSEcCtD
Posaconazole—Nausea—Mitoxantrone—lymphatic system cancer	0.000186	0.000389	CcSEcCtD
Posaconazole—Back pain—Methotrexate—lymphatic system cancer	0.000185	0.000386	CcSEcCtD
Posaconazole—Vision blurred—Methotrexate—lymphatic system cancer	0.00018	0.000376	CcSEcCtD
Posaconazole—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000177	0.00037	CcSEcCtD
Posaconazole—Anaemia—Methotrexate—lymphatic system cancer	0.000177	0.000369	CcSEcCtD
Posaconazole—Malaise—Methotrexate—lymphatic system cancer	0.000172	0.00036	CcSEcCtD
Posaconazole—Vertigo—Methotrexate—lymphatic system cancer	0.000172	0.000359	CcSEcCtD
Posaconazole—Leukopenia—Methotrexate—lymphatic system cancer	0.000171	0.000357	CcSEcCtD
Posaconazole—Cough—Methotrexate—lymphatic system cancer	0.000167	0.000348	CcSEcCtD
Posaconazole—Convulsion—Methotrexate—lymphatic system cancer	0.000165	0.000346	CcSEcCtD
Posaconazole—Arthralgia—Methotrexate—lymphatic system cancer	0.000163	0.00034	CcSEcCtD
Posaconazole—Chest pain—Methotrexate—lymphatic system cancer	0.000163	0.00034	CcSEcCtD
Posaconazole—Myalgia—Methotrexate—lymphatic system cancer	0.000163	0.00034	CcSEcCtD
Posaconazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000161	0.000338	CcSEcCtD
Posaconazole—Discomfort—Methotrexate—lymphatic system cancer	0.000161	0.000336	CcSEcCtD
Posaconazole—Confusional state—Methotrexate—lymphatic system cancer	0.000157	0.000329	CcSEcCtD
Posaconazole—Infection—Methotrexate—lymphatic system cancer	0.000155	0.000324	CcSEcCtD
Posaconazole—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000153	0.00032	CcSEcCtD
Posaconazole—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000153	0.000319	CcSEcCtD
Posaconazole—Skin disorder—Methotrexate—lymphatic system cancer	0.000151	0.000317	CcSEcCtD
Posaconazole—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000151	0.000315	CcSEcCtD
Posaconazole—Anorexia—Methotrexate—lymphatic system cancer	0.000149	0.000311	CcSEcCtD
Posaconazole—Hypotension—Methotrexate—lymphatic system cancer	0.000146	0.000305	CcSEcCtD
Posaconazole—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000142	0.000297	CcSEcCtD
Posaconazole—Insomnia—Methotrexate—lymphatic system cancer	0.000141	0.000295	CcSEcCtD
Posaconazole—Paraesthesia—Methotrexate—lymphatic system cancer	0.00014	0.000293	CcSEcCtD
Posaconazole—Dyspnoea—Methotrexate—lymphatic system cancer	0.000139	0.000291	CcSEcCtD
Posaconazole—Somnolence—Methotrexate—lymphatic system cancer	0.000139	0.00029	CcSEcCtD
Posaconazole—Dyspepsia—Methotrexate—lymphatic system cancer	0.000137	0.000287	CcSEcCtD
Posaconazole—Decreased appetite—Methotrexate—lymphatic system cancer	0.000136	0.000283	CcSEcCtD
Posaconazole—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000135	0.000281	CcSEcCtD
Posaconazole—Fatigue—Methotrexate—lymphatic system cancer	0.000134	0.000281	CcSEcCtD
Posaconazole—Pain—Methotrexate—lymphatic system cancer	0.000133	0.000279	CcSEcCtD
Posaconazole—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000128	0.000269	CcSEcCtD
Posaconazole—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000127	0.000266	CcSEcCtD
Posaconazole—Urticaria—Methotrexate—lymphatic system cancer	0.000124	0.000259	CcSEcCtD
Posaconazole—Abdominal pain—Methotrexate—lymphatic system cancer	0.000123	0.000258	CcSEcCtD
Posaconazole—Body temperature increased—Methotrexate—lymphatic system cancer	0.000123	0.000258	CcSEcCtD
Posaconazole—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000115	0.00024	CcSEcCtD
Posaconazole—Asthenia—Methotrexate—lymphatic system cancer	0.000112	0.000234	CcSEcCtD
Posaconazole—Pruritus—Methotrexate—lymphatic system cancer	0.00011	0.000231	CcSEcCtD
Posaconazole—Diarrhoea—Methotrexate—lymphatic system cancer	0.000107	0.000223	CcSEcCtD
Posaconazole—Dizziness—Methotrexate—lymphatic system cancer	0.000103	0.000215	CcSEcCtD
Posaconazole—Vomiting—Methotrexate—lymphatic system cancer	9.91e-05	0.000207	CcSEcCtD
Posaconazole—Rash—Methotrexate—lymphatic system cancer	9.83e-05	0.000205	CcSEcCtD
Posaconazole—Dermatitis—Methotrexate—lymphatic system cancer	9.82e-05	0.000205	CcSEcCtD
Posaconazole—Headache—Methotrexate—lymphatic system cancer	9.77e-05	0.000204	CcSEcCtD
Posaconazole—Nausea—Methotrexate—lymphatic system cancer	9.26e-05	0.000194	CcSEcCtD
